Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Wortmannin
As low as
CHF 45.00
In stock
Only %1 left
AG-CN2-0023-M0011 mgCHF 45.00
AG-CN2-0023-M0055 mgCHF 85.00
AG-CN2-0023-M02525 mgCHF 255.00
Specifications / Handling
| Product Details | |
|---|---|
| Synonyms | KY 12420; BRN 0067676; NSC 627609; Antibiotic SL-2052 |
| Product Type | Chemical |
| Properties | |
| Formula |
C23H24O8 |
| MW | 428.4 |
| Merck Index | 14: 10053 |
| CAS | 19545-26-7 |
| RTECS | CB9641000 |
| Source/Host Chemicals | Isolated from Penicillium wortmannii synonym Talaromyces wortmannii. |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | White to light yellow solid. |
| Solubility | Soluble in DMSO methanol, ethanol or chloroform. Slightly soluble in water. |
| InChi Key | QDLHCMPXEPAAMD-QAIWCSMKSA-N |
| Smiles | [H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Keep cool and dry. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| Safety Data Sheet |
Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Scientific Background Information
Product Description
- Antibiotic [1].
- Potent anti-neutrophil agent with cardioprotective effects [1, 13].
- mTOR, DNA-PK, phosphatidylinositol 4-kinases, myosin light chain kinase (MLCK) and mitogen-activated protein kinase (MAPK) inhibitor at high concentrations [2, 5, 14].
- Potent cell permeable and selective inhibitor of phosphatidyl-inositol 3-kinase (PI3K) [3, 4].
- Similar potency in vitro for the class I, II, and III PI3K.
- Antitumor compound. [6] Radiosensitizing agent [8].
- Adipogenesis inhibitor [5, 7]. Angiogenesis inhibitor. [10]
- Autophagy inhibitor, regardless of the nutrient status and thus is a more suitable autophagy inhibitor than 3-MA [12,18].
- DNA repair, receptor-mediated endocytosis and cell proliferation inhibitor [8, 9, 14].
- Potentiates the LPS-induced nitric oxide (NO) production from macrophages [11].
- Induces in vivo Alzheimer-like hyperphosphorylation in tau [15].
- Polo-like kinase family inhibitor [16].
- TRAIL sensitizer [19]
Product-specific References
- Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil: R.W. Bonser, et al.; Br. J. Pharmacol. 103, 1237 (1991)
- Wortmannin, a microbial product inhibitor of myosin light chain kinase: S. Nakanishi, et al.; J. Biol. Chem. 267, 2157 (1992)
- Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses: A. Arcaro & M.P. Wyman; Biochem. J. 296, 297 (1993)
- Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase: G. Powis, et al.; Cancer Res. 54, 2419 (1994)
- Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase: G.I. Welsh, et al.; Biochem. J. 303, 15 (1994)
- In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin: R.M. Schultz, et al.; Anticancer Res. 15, 1135 (1995)
- Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells: K. Tomiyama, et al.; BBRC 212, 263 (1995)
- The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage: B.D. Price & M.B. Youmell; Cancer Res. 56, 246 (1996)
- Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells: S. Boulton, et al.; Carcinogenesis 17, 2285 (1996)
- Potent inhibition of angiogenesis by wortmannin, a fungal metabolite: T. Oikawa & M. Shimamura; Eur. J. Pharmacol. 318, 93 (1996)
- Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages: Y.C. Park, et al.; BBRC 240, 692 (1997)
- The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes: E.F. Blommaart, et al.; Eur. J. Biochem. 243, 240 (1997)
- Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion: L.H. Young, et al.; J. Pharmacol. Exp. Ther. 295, 37 (2000)
- DNA-PK inhibitor wortmannin enhances DNA damage induced by bleomycin in V79 Chinese hamster cells: N.G. Oliveira, et al.; Teratog. Carcinog. Mutagen. 22, 343 (2002)
- Alzheimer-like tau phosphorylation induced by wortmannin in vivo and its attenuation by melatonin: S.J. Liu & J.Z. Wang; Acta Pharmacol. Sin. 23, 183 (2002)
- Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase: Y. Liu, et al.; Chem. Biol. 12, 99 (2005)
- Chemistry and biology of wortmannin: P. Wipf & R.J. Halter; Org. Biomol. Chem. 3, 2053 (2005)
- Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase: YT. Wu, et al.; J. Biol. Chem. 285, 10850 (2010)
- Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the Caspase-8 apoptotic axis: D. Finlay, et al.;PLoS One 5, e13375 (2010)
- Insulin inhibits AMPK activity and phosphorylates AMPK Ser485/491 through Akt in hepatocytes, myotubes and incubated rat skeletal muscle: R.J. Valentine, et al.; Arch. Biochem. Biophys. 562, 62 (2014)
You're in the Switzerland store. Not in Switzerland? Choose your country
You're in the Switzerland store (prices in CHF, shipping to Switzerland only). Ordering from another country? Please select it below.
Please note that not all products are available in every country store. Choose your country before starting the ordering process.
Country
Switzerland
United Kingdom
France
Germany
Austria
Italy
South Korea
United States
Argentina
Australia
Belgium
Bosnia and Herzegovina
Brazil
Canada
Chile
China
Colombia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
Greece
Hong Kong
Hungary
India
Iran
Iraq
Ireland
Israel
Japan
Latvia
Lithuania
Luxembourg
Malaysia
Mexico
Netherlands
New Zealand
Norway
Pakistan
Peru
Poland
Portugal
Romania
Russia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Syria
Taiwan
Thailand
Turkey
Uruguay
Venezuela
Other Country
No country found




Download PDF

